In xenograft and transgenic mouse models of MYCN-amplified neuroblastoma, dipyridamole at the doses of 100–200 mg/kg synergized with BRQ to suppress tumor growth and to extend the survival of tumor-bearing mice. This evidence concerns the gene MYCN and neuroblastoma.